ARF inhibits the growth and malignant progression of non-small-cell lung carcinoma
- PMID: 23752194
- PMCID: PMC3839253
- DOI: 10.1038/onc.2013.208
ARF inhibits the growth and malignant progression of non-small-cell lung carcinoma
Abstract
Non-small-cell lung carcinoma (NSCLC) is among the deadliest of human cancers. The CDKN2A locus, which houses the INK4a and ARF tumor suppressor genes, is frequently altered in NSCLC. However, the specific role of ARF in pulmonary tumorigenesis remains unclear. KRAS and other oncogenes induce the expression of ARF, thus stabilizing p53 activity and arresting cell proliferation. To address the role of ARF in Kras-driven NSCLC, we compared the susceptibility of NIH/Ola strain wild-type and Arf-knockout mice to urethane-induced lung carcinogenesis. Lung tumor size, malignancy and associated morbidity were significantly increased in Arf(-/-) compared with Arf(+/+) animals at 25 weeks after induction. Pulmonary tumors from Arf-knockout mice exhibited increased cell proliferation and DNA damage compared with wild-type mice. A subgroup of tumors in Arf(-/-) animals presented as dedifferentiated and metastatic, with many characteristics of pulmonary sarcomatoid carcinoma, a neoplasm previously undocumented in mouse models. Our finding of a role for ARF in NSCLC is consistent with the observation that benign adenomas from Arf(+/+) mice robustly expressed ARF, while ARF expression was markedly reduced in malignant adenocarcinomas. ARF expression also frequently colocalized with the expression of p21(CIP1), a transcriptional target of p53, arguing that ARF induces the p53 checkpoint to arrest cell proliferation in vivo. Taken together, these findings demonstrate that induction of ARF is an early response in lung tumorigenesis that mounts a strong barrier against tumor growth and malignant progression.
Conflict of interest statement
The authors have no conflict of interest to declare.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3839253/bin/nihms490151f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3839253/bin/nihms490151f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3839253/bin/nihms490151f3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3839253/bin/nihms490151f4.gif)
Similar articles
-
Roles of ARF tumour suppressor protein in lung cancer: time to hit the nail on the head!Mol Cell Biochem. 2021 Mar;476(3):1365-1375. doi: 10.1007/s11010-020-03996-0. Epub 2021 Jan 3. Mol Cell Biochem. 2021. PMID: 33392921 Review.
-
Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.Cancer Res. 2003 Aug 1;63(15):4389-95. Cancer Res. 2003. PMID: 12907609
-
Nullifying the CDKN2AB locus promotes mutant K-ras lung tumorigenesis.Mol Cancer Res. 2014 Jun;12(6):912-23. doi: 10.1158/1541-7786.MCR-13-0620-T. Epub 2014 Mar 11. Mol Cancer Res. 2014. PMID: 24618618 Free PMC article.
-
p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways.PLoS Biol. 2004 Aug;2(8):E242. doi: 10.1371/journal.pbio.0020242. Epub 2004 Aug 17. PLoS Biol. 2004. PMID: 15314658 Free PMC article.
-
Genetic Alterations in the INK4a/ARF Locus: Effects on Melanoma Development and Progression.Biomolecules. 2020 Oct 15;10(10):1447. doi: 10.3390/biom10101447. Biomolecules. 2020. PMID: 33076392 Free PMC article. Review.
Cited by
-
Long non-coding RNAs: Promising new targets in pulmonary fibrosis.J Gene Med. 2021 Mar;23(3):e3318. doi: 10.1002/jgm.3318. Epub 2021 Feb 11. J Gene Med. 2021. PMID: 33533071 Free PMC article. Review.
-
Roles of ARF tumour suppressor protein in lung cancer: time to hit the nail on the head!Mol Cell Biochem. 2021 Mar;476(3):1365-1375. doi: 10.1007/s11010-020-03996-0. Epub 2021 Jan 3. Mol Cell Biochem. 2021. PMID: 33392921 Review.
-
Exosomal Long Non-Coding RNAs in Lung Diseases.Int J Mol Sci. 2020 May 19;21(10):3580. doi: 10.3390/ijms21103580. Int J Mol Sci. 2020. PMID: 32438606 Free PMC article. Review.
-
Low expression of long noncoding RNA CDKN2B-AS1 in patients with idiopathic pulmonary fibrosis predicts lung cancer by regulating the p53-signaling pathway.Oncol Lett. 2018 Apr;15(4):4912-4918. doi: 10.3892/ol.2018.7910. Epub 2018 Jan 31. Oncol Lett. 2018. PMID: 29541247 Free PMC article.
-
Differing tumor-suppressor functions of Arf and p53 in murine basal cell carcinoma initiation and progression.Oncogene. 2017 Jun 29;36(26):3772-3780. doi: 10.1038/onc.2017.12. Epub 2017 Mar 6. Oncogene. 2017. PMID: 28263978
References
-
- SEER Cancer Statistics Review, 1975–2008. Bethesda, MD: National Cancer Institute; Available from: http://seer.cancer.gov/csr/1975_2008/.
-
- Quelle DE, Zindy F, Ashmun RA, Sherr CJ. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell. 1995;83:993–1000. - PubMed
-
- Sharpless NE. INK4a/ARF: a multifunctional tumor suppressor locus. Mutat Res. 2005;576:22–38. - PubMed
-
- Sherr CJ. Divorcing ARF and p53: an unsettled case. Nat Rev Cancer. 2006;6:663–673. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous